NAV1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.857000E-01
Normal-vs-Stage2
4.232800E-01
Normal-vs-Stage3
8.565000E-01
Normal-vs-Stage4
2.277400E-01
Stage1-vs-Stage2
7.421200E-01
Stage1-vs-Stage3
8.308200E-01
Stage1-vs-Stage4
3.252800E-01
Stage2-vs-Stage3
5.417800E-01
Stage2-vs-Stage4
1.725570E-01
Stage3-vs-Stage4
2.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.050000E-01
Normal-vs-AfricanAmerican
3.820000E-01
Normal-vs-Asian
6.882800E-01
Caucasian-vs-AfricanAmerican
6.343200E-01
Caucasian-vs-Asian
3.786600E-01
AfricanAmerican-vs-Asian
3.365400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.484200E-01
Normal-vs-Female
3.548400E-01
Male-vs-Female
9.147600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.333800E-01
Normal-vs-Age(41-60Yrs)
1.569600E-01
Normal-vs-Age(61-80Yrs)
4.862400E-01
Normal-vs-Age(81-100Yrs)
8.487600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.227000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.865800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.574800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.499440E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.657900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.568800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.797600E-01
Normal-vs-Daily Drinker
8.072600E-01
Normal-vs-Weekly Drinker
3.308200E-01
Normal-vs-Occasional Drinker
1.842000E-01
Normal-vs-Social Drinker
4.307400E-01
Non Drinker-vs-Daily Drinker
8.504400E-01
Non Drinker-vs-Weekly Drinker
2.848800E-01
Non Drinker-vs-Occasional Drinker
1.145730E-02
Non Drinker-vs-Social Drinker
1.880370E-01
Daily Drinker-vs-Weekly Drinker
1.687040E-01
Daily Drinker-vs-Occasional Drinker
1.166100E-02
Daily Drinker-vs-Social Drinker
1.827000E-01
Weekly Drinker-vs-Occasional Drinker
1.686600E-01
Weekly Drinker-vs-Social Drinker
7.263200E-01
Occasional Drinker-vs-Social Drinker
3.813000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.454200E-01
Normal-vs-Grade 2
1.192040E-01
Normal-vs-Grade 3
2.149800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.025000E-01
Grade 1-vs-Grade 3
4.794800E-01
Grade 1-vs-Grade 4
3.454200E-01
Grade 2-vs-Grade 3
5.853400E-01
Grade 2-vs-Grade 4
1.192040E-01
Grade 3-vs-Grade 4
2.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.074000E-01
Normal-vs-NonDiabetic
4.123000E-01
Diabetic-vs-NonDiabetic
3.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.404400E-01
Normal-vs-NoPancreatitis
4.511600E-01
Pancreatitis-vs-NoPancreatitis
1.070590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.709000E-01
Normal-vs-N1
3.849200E-01
N0-vs-N1
5.234600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.005000E-01
Normal-vs-TP53-NonMutant
6.303400E-01
TP53-Mutant-vs-TP53-NonMutant
4.969200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
